Response to Comments: MolDX: EndoPredict® Breast Cancer Gene Expression Test (DL37663).

WPS GHA reported that it received no comments on the Draft Local Coverage Determination MolDX: EndoPredict® Breast Cancer Gene Expression Test (DL37663). No stakeholder feedback or amendments are noted in this notice; refer to the published DL37663 LCD for the active coverage criteria, limitations, documentation, and frequency rules.